89 related articles for article (PubMed ID: 34079765)
21. A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy.
Li Y; Tian M; Zhou Y; Tan F; Liu W; Zhao L; Perez D; Song X; Wang D; Nitschke C; Pei Q; Güngör C
J Cancer; 2021; 12(14):4433-4442. PubMed ID: 34093844
[No Abstract] [Full Text] [Related]
22. Trends in treatments for prostate cancer in the United States, 2010-2015.
Wang J; Xia HH; Zhang Y; Zhang L
Am J Cancer Res; 2021; 11(5):2351-2368. PubMed ID: 34094691
[TBL] [Abstract][Full Text] [Related]
23. The first competing risk survival nomogram in patients with papillary renal cell carcinoma.
Su X; Hou NN; Yang LJ; Li PX; Yang XJ; Hou GD; Gao XL; Ma SJ; Guo F; Zhang R; Zhang WH; Qin WJ; Wang FL
Sci Rep; 2021 Jun; 11(1):11835. PubMed ID: 34088935
[TBL] [Abstract][Full Text] [Related]
24. Surgery or Non-surgical Treatment of ≤8 mm Non-small Cell Lung Cancer: A Population-Based Study.
Shen J; Zhuang W; Xu C; Jin K; Chen B; Tian D; Hiley C; Onishi H; Zhu C; Qiao G
Front Surg; 2021; 8():632561. PubMed ID: 34124131
[No Abstract] [Full Text] [Related]
25. Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study.
Yin L; Zhao S; Zhu H; Ji G; Zhang X
Sci Rep; 2021 Jun; 11(1):12166. PubMed ID: 34108604
[TBL] [Abstract][Full Text] [Related]
26. Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based Analysis.
Afifi AM; Elmehrath AO; Ruhban IA; Saad AM; Gad MM; Al-Husseini MJ; Bekaii-Saab T; Sonbol MB
Oncologist; 2021 Sep; 26(9):733-739. PubMed ID: 34101294
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
28. Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.
Beyer KMM; Zhou Y; Laud PW; McGinley EL; Yen TWF; Jankowski C; Rademacher N; Namin S; Kwarteng J; Beltrán Ponce S; Nattinger AB
J Clin Oncol; 2021 Sep; 39(25):2749-2757. PubMed ID: 34129388
[TBL] [Abstract][Full Text] [Related]
29. Clinical Factors and Outcomes of Atypical Meningioma: A Population-Based Study.
Zhang GJ; Liu XY; You C
Front Oncol; 2021; 11():676683. PubMed ID: 34123845
[TBL] [Abstract][Full Text] [Related]
30. Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study.
Qiu G; Zhang H; Wang F; Zheng Y; Wang Z; Wang Y
Front Oncol; 2021; 11():625720. PubMed ID: 34123784
[TBL] [Abstract][Full Text] [Related]
31. Nomogram for Predicting the Relationship between the Extent of Visceral Pleural Invasion and Survival in Non-Small-Cell Lung Cancer.
Wang F; Li P; Li F
Can Respir J; 2021; 2021():8816860. PubMed ID: 34122679
[TBL] [Abstract][Full Text] [Related]
32. Nomograms for Predicting Prognosis of Primary Mediastinal Seminoma: A Population-Based Study.
Huang W; Luo J; Zhou X; Zhao Y; Zhang T; Ma X
J Oncol; 2021; 2021():9048375. PubMed ID: 34113380
[TBL] [Abstract][Full Text] [Related]
33. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
Wu J; Li L; Zhang H; Zhao Y; Zhang H; Wu S; Xu B
Oncogene; 2021 Jul; 40(26):4413-4424. PubMed ID: 34108619
[TBL] [Abstract][Full Text] [Related]
34. Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database.
Li W; Dong S; Wang H; Wu R; Wu H; Tang ZR; Zhang J; Hu Z; Yin C
BMC Musculoskelet Disord; 2021 Jun; 22(1):529. PubMed ID: 34107945
[TBL] [Abstract][Full Text] [Related]
35. Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.
Al Hussein Al Awamlh B; Patel N; Ma X; Calaway A; Ponsky L; Hu JC; Shoag JE
Front Oncol; 2021; 11():644885. PubMed ID: 34094931
[TBL] [Abstract][Full Text] [Related]
36. Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Jabbour SK; Lee KH; Frost N; Breder V; Kowalski DM; Pollock T; Levchenko E; Reguart N; Martinez-Marti A; Houghton B; Paoli JB; Safina S; Park K; Komiya T; Sanford A; Boolell V; Liu H; Samkari A; Keller SM; Reck M
JAMA Oncol; 2021 Jun; 7(9):1-9. PubMed ID: 34086039
[TBL] [Abstract][Full Text] [Related]
37. Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease.
Erickson AW; Habbous S; Wright F; Lofters AK; Jerzak KJ; Das S
JAMA Oncol; 2021 Aug; 7(8):1220-1224. PubMed ID: 34081080
[TBL] [Abstract][Full Text] [Related]
38. PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions.
Jiang LR; Zhang N; Chen ST; He J; Liu YH; Han YQ; Shi XQ; Yang JJ; Mu DY; Fu GH; Gao F
Front Oncol; 2021; 11():679928. PubMed ID: 34079767
[TBL] [Abstract][Full Text] [Related]
39. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.
Fu M; Feng C; Wang J; Guo C; Wang Y; Gao R; Wang J; Zhu Q; Zhang X; Qi J; Zhang Y; Bian Y; Wang Z; Fang Y; Cao L; Hong B; Wang H
Clin Exp Med; 2024 May; 24(1):99. PubMed ID: 38748269
[TBL] [Abstract][Full Text] [Related]
40. Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis.
Bian D; Jiang S; Xiong Y; Qi M; Wu J; Addeo A; Yamauchi Y; Manapov F; Dempke WCM; Vannucci J; Di Federico A; Xu X; Chen L
Transl Lung Cancer Res; 2022 Aug; 11(8):1631-1642. PubMed ID: 36090643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
